$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

In vitro peptide and antibody display libraries 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12Q-001/68
  • C12Q-001/70
  • G01N-033/53
출원번호 US-0902623 (1997-07-29)
발명자 / 주소
  • Mattheakis Larry C.
  • Dower William J.
출원인 / 주소
  • Affymax Technologies N.V., GBX
대리인 / 주소
    Stevens
인용정보 피인용 횟수 : 103  인용 특허 : 6

초록

Improved methods and novel compositions for identifying peptides and single-chain antibodies that bind to predetermined receptors or epitopes. Such peptides and antibodies are identified by improved and novel methods for affinity screening of polysomes displaying nascent peptides.

대표청구항

[ We claim:] [1.] A method for identifying multiple binding specificities of single chain antibodies, said method comprising:contacting under suitable binding conditions a multiplicity of antigen species with a polysome library displaying nascent peptides having a single chain antibody segment; ands

이 특허에 인용된 특허 (6)

  1. Ladner Robert C. (Ijamsville MD) Guterman Sonia K. (Belmont MA) Roberts Bruce L. (Milford MA) Markland William (Milford MA) Ley Arthur C. (Newton MA) Kent Rachel B. (Boxborough MA), Directed evolution of novel binding proteins.
  2. Houghten Richard A. (Solana Beach CA), Means for sequential solid phase organic synthesis and methods using the same.
  3. Lam Kit S. (Tucson AZ) Salmon Sydney E. (Tucson AZ), Method of screening a peptide library.
  4. Schatz Peter J. (Los Altos CA) Cull Millard G. (Oakland CA) Miller Jeff F. (Los Angeles CA), Peptide library and screening method.
  5. Mullis Kary B. (Kensington CA), Process for amplifying nucleic acid sequences.
  6. Mullis Kary B. (La Jolla CA) Erlich Henry A. (Oakland CA) Gelfand David H. (Oakland CA) Horn Glenn (Emeryville CA) Saiki Randall K. (Richmond CA), Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme.

이 특허를 인용한 특허 (103)

  1. Zhao, Robert Yongxin, Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule.
  2. Hallahan, Dennis E.; Yan, Heping, Antibodies to GRP78.
  3. Hallahan, Dennis E.; Yan, Heping, Antibodies to TIP-1.
  4. Vasquez, Maximiliano; Sivasubramanian, Arvind; Feldhaus, Michael, Antibody libraries.
  5. Vasquez, Maximiliano; Sivasubramanian, Arvind; Feldhaus, Michael, Antibody libraries.
  6. Kohno, Tadahiko, Apo-AI/AII peptide derivatives.
  7. Grant, Steven; Liu, Haiqun; Moulder, Kevin, CD40L-specific monovalent polypeptides.
  8. Smith, Craig A.; Wiley, Steven; Kaykas, Ajamete; Probst, Peter, CD47 related compositions and methods for treating immunological diseases and disorders.
  9. Harvey,Barrett R.; Georgiou,George; Iverson,Brent L., Combinatorial protein library screening by periplasmic expression.
  10. Achilefu, Samuel; Black, Kvar, Compositions and methods for treatment and imaging using nanoparticles.
  11. Simpson,Daniel J.; Johnson,Tonny M.; Flemming,Roderick G., Compositions for separating molecules.
  12. Simpson,Daniel J.; Johnson,Tonny; Flemming,Roderick G., Compositions for separating molecules.
  13. Simpson,Daniel J.; Johnson,Tonny; Flemming,Roderick G., Compositions for separating molecules.
  14. Lohse,Peter; Kurz,Markus, DNA-protein fusions and uses thereof.
  15. Anderson, Norman G.; Anderson, N. Leigh; Braatz, James A., Dry deposition of materials for microarrays using matrix displacement.
  16. Liu, David R.; Gartner, Zev J.; Calderone, Christopher T., Evolving new molecular function.
  17. Liu, David R.; Gartner, Zev J.; Doyon, Jeffrey B.; Calderone, Christopher T.; Kanan, Matthew W.; Li, Xiaoyu; Snyder, Thomas M.; Rosenbaum, Daniel M., Evolving new molecular function.
  18. Liu, David R.; Gartner, Zev J.; Kanan, Matthew W., Evolving new molecular function.
  19. Liu, David R.; Gartner, Zev J.; Kanan, Matthew W., Evolving new molecular function.
  20. Liu,David R.; Gartner,Zev J.; Calderone,Christopher T., Evolving new molecular function.
  21. Liu,David R.; Gartner,Zev J.; Kanan,Matthew W., Evolving new molecular function.
  22. Liu,David R.; Gartner,Zev J.; Kanan,Matthew W., Evolving new molecular function.
  23. Liu,David R.; Gartner,Zev; Kanan,Matthew W., Evolving new molecular function.
  24. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  25. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  26. Liu, David R.; Sakurai, Kaori, Free reactant use in nucleic acid-templated synthesis.
  27. Li Zhu ; Shaobing Benjamin Hua, Generation of highly diverse library of expression vectors via homologous recombination in yeast.
  28. Barden, Michael C.; Kambouris, Peter A., Generation of surface coating diversity.
  29. Marshall, William S.; Stark, Kevin Lee, Glucagon antagonists.
  30. Sasu, Barbra; Haniu, Mitsuru; Boone, Thomas Charles; Bi, Xiao-juan; Lee, Grace Ki Jeong; Arvedson, Tara; Winters, Aaron George; Cooke, Keegan; Sheng, Jackie Z., Hepcidin, hepcidin antagonists and methods of use.
  31. Zhu, Li; Wei, Shuanghong; Hua, Shaobing B., High throughput generation and affinity maturation of humanized antibody.
  32. Li Zhu ; Shaobing Benjamin Hua, High throughput generation and screening of fully human antibody repertoire in yeast.
  33. Li Zhu ; Shaobing Benjamin Hua, Highly diverse library of yeast expression vectors.
  34. Thompson,Catherine C., Human hairless antibodies.
  35. Hua, Shaobing; Pauling, Michelle Haynes; Zhu, Li, Human monoclonal antibody against coreceptors for human immunodeficiency virus.
  36. Zhao, R. Yongxin, Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules.
  37. Bertozzi, Carolyn R.; Song, Jie; Lee, Seung-Wuk, Hydroxyapatite-binding peptides for bone growth and inhibition.
  38. Georgiou, George; Mazor, Yariv, Immunoglobulin libraries.
  39. Georgiou, George; Mazor, Yariv, Immunoglobulin libraries.
  40. Georgiou, George; Mazor, Yariv, Immunoglobulin libraries.
  41. Lindqvist,Bjorn H.; Andrews,David; Haggard Ljungquist,Elizabeth; Isaksen,Morten, In vitro peptide or protein expression library.
  42. Chen, Gang; Hayhurst, Andrew; Thomas, Jeffrey G.; Iverson, Brent L.; Georgiou, George, Isolation of binding proteins with high affinity to ligands.
  43. Chen,Gang; Hayhurst,Andrew; Thomas,Jeffrey G.; Iverson,Brent L.; Georgiou,George, Isolation of binding proteins with high affinity to ligands.
  44. Hallahan, Dennis E.; Qu, Shimian; Han, Zhaozhong, Ligands to radiation-induced molecules.
  45. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  46. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  47. Gorse, Alain-Dominique Jean-Pierre, Method for designing surfaces.
  48. Charles Everett Merryman ; David P. Bartel, Method for producing diverse libraries of encoded polypeptides.
  49. Fiacco, Stephen V.; Takahashi, Terry T.; Roberts, Richard W., Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same.
  50. Simpson,Daniel J.; Johnson,Tonny; Shultz,John; Flemming,Roderick G.; Godat,Rebecca; Kar,Sanchayita; Hurst,Robin, Methods for separating molecules.
  51. Hsieh, Chung-Ming; Kutskova, Yuliya A.; Memmott, John E., Methods of RNA display.
  52. Grant, Steven; Liu, Haiqun; Moulder, Kevin, Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals.
  53. Li,Min, Methods of detection utilizing modified bacteriophage.
  54. Anderson, Norman G.; Anderson, N. Leigh, Microarrays and their manufacture.
  55. Anderson, Norman G.; Anderson, N. Leigh, Microarrays and their manufacture.
  56. Anderson, Norman G.; Anderson, N. Leigh; Braatz, James A., Microarrays and their manufacture.
  57. Anderson,N. Leigh; Anderson,Norman G.; Braatz,James A., Microarrays and their manufacture by slicing.
  58. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  59. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  60. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  61. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  62. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  63. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  64. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  65. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  66. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  67. Gegg,Colin; Xiong,Fei; Sitney,Karen C., Modified Fc molecules.
  68. Feige, Ulrich; Liu, Chuan-Fa, Modified peptides as therapeutic agents.
  69. Feige,Ulrich, Modified peptides as therapeutic agents.
  70. Feige,Ulrich, Modified peptides as therapeutic agents.
  71. Feige,Ulrich, Modified peptides as therapeutic agents.
  72. Feige,Ulrich, Modified peptides as therapeutic agents.
  73. Feige,Ulrich; Liu,Chuan Fa; Cheetham,Janet C.; Boone,Thomas Charles; Gudas,Jean Marie, Modified peptides as therapeutic agents.
  74. Bertin, John, Molecules of the card-related protein family and uses thereof.
  75. Grant, Steven; Liu, Haiqun; Moulder, Kevin, Monovalent anti-CD40L antibody polypeptides and compositions thereof.
  76. Herkel, Johannes; Cohen, Irun R.; Rotter, Varda; Lohse, Ansgar W.; Erez, Neta; Mimran, Avishai; Kam, Na'aman, Peptide inhibitors for mediating stress responses.
  77. Herkel, Johannes; Cohen, Irun R.; Rotter, Varda; Lohse, Ansgar W.; Erez, Neta; Mimran, Avishai; Kam, Na'aman, Peptide inhibitors for mediating stress responses.
  78. Min,Hosung; Sitney,Karen C.; Hartley,Cynthia, Peptides and related compounds having thrombopoietic activity.
  79. Min, Hosung; Hsu, Hailing; Xiong, Fei, Peptides and related molecules that bind to TALL-1.
  80. Min, Hosung; Hsu, Hailing; Xiong, Fei, Peptides and related molecules that bind to TALL-1.
  81. Min,Hosung; Hsu,Hailing; Xiong,Fei, Peptides and related molecules that bind to TALL-1.
  82. Pluckthun, Andreas; Hanes, Jozef; Jermutus, Lutz, Polysome display in the absence of functional ssrA-RNA.
  83. Delisa, Matthew P.; Contreras-Martinez, Lydia, Protein discovery using intracellular ribosome display.
  84. Wagner, Richard W.; Litovchick, Alexander; Chen, Yan, Protein screening methods.
  85. Wagner, Richard W.; Litovchick, Alexander; Chen, Yan, Protein screening methods.
  86. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  87. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  88. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  89. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  90. Liu, David R.; Kanan, Matthew William; Rozenman, Mary M., Reaction discovery system.
  91. Georgiou, George; Jeong, Ki Jun; Harvey, Barrett R.; Iverson, Brent L., Selection of bacterial inner-membrane anchor polypeptides.
  92. Fischer, Nicolas; Kosco-Vilbois, Marie; Ravn, Ulla; Gueneau, Franck; Venet-Bonnot, Sophie, Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants.
  93. Walker, Kenneth W.; Kinstler, Olaf B.; Sitney, Karen C., Therapeutic peptides.
  94. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  95. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  96. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  97. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  98. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  99. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  100. Min, Hosung; Walker, Kenneth W.; Gegg, Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  101. Min, Hosung; Walker, Kenneth W.; Gegg, Jr., Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  102. Stafford, Ryan; Thanos, Christopher D., Use of LAMBDA-GAM protein in ribosomal display technology.
  103. Muir, Benjamin Ward; Barden, Michael C.; Rylatt, Dennis Brian; Maeji, N. Joe; Hillyard, Carmel Judith; Gorse, Alain-Dominique Jean-Pierre; Monteiro, Raisa Leonidovna, Use of metal complexes.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로